Role of photodynamic therapy in polypoidal choroidal vasculopathy

Indian Journal of Ophthalmology

Volumn 53, Issue 2, 2005, Pages 101-104

  Hussain, Nazimul ^a   Hussain, Anjli ^a   Natarajan, Sundaram ^b  

^a L V PRASAD EYE INSTITUTE   (India)

^b ADITYA JYOT EYE HOSPITAL PVT LTD   (India)

Author keywords

Photodynamic therapy; Pigment epithelial detachment; Sub retinal pigment epithelial haemorrhage; Verteporfin

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; COLORING AGENT; DIAGNOSTIC AGENT; INDOCYANINE GREEN; PHOTOSENSITIZING AGENT; PORPHYRIN;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; CHOROID DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; EVALUATION; FEMALE; FOLLOW UP; HUMAN; INFORMATION RETRIEVAL; MALE; MEDICAL RECORD; PHOTODYNAMIC THERAPY; POLYPOIDAL CHOROIDAL VASCULOPATHY; RETINA FOVEA; RETROSPECTIVE STUDY; TREATMENT OUTCOME; TREATMENT RESPONSE; VISUAL ACUITY; CHOROID; FLUORESCENCE ANGIOGRAPHY; MIDDLE AGED; PATHOLOGY; PHOTOCHEMOTHERAPY; PIGMENT EPITHELIUM; VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; CHOROID; CHOROID DISEASES; COLORING AGENTS; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOVEA CENTRALIS; HUMANS; INDOCYANINE GREEN; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PIGMENT EPITHELIUM OF EYE; PORPHYRINS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 23244438135     PISSN: 03014738     EISSN: 03014738     Source Type: Journal    
DOI: 10.4103/0301-4738.16172     Document Type: Article

References (18)

1. Yannuzzi LA, Sorenson J, Spaide RF, Lipson B. Idiopathic polypoidal choroidal vasculopathy. Retina 1990;10:18.
2. Spaide RF, Yannuzzi LA, Slakter JS, Sorenson J, Orlack DA. Indocyanine green videoangiography of idiopathic choroidal vasculopathy. Retina 1995;15:100-10.
3. Yannuzzi LA, Ciardella A, Spaide RF, Rabb M, Freund KB, Orlack DA. The expanding clinical spectrum of idiopathic polypoidal choroidal vasculopathy. Arch Ophthalmol 1997;115:478-85.
4. Perkovich BT, Zakov ZN, Berlin LA, Weindenthal D, Avins LR. An update of multiple recurrent serosanguinous detachment in black women. Retina 1990;10:18-26.
5. Kleiner RC, Brucker AJ, Johnson RL. The posterior uvealbleeding syndrome. Retina 1990;10:9-17.
6. Moorthy RS, Lyon AT, Rabb MF, Spaide RF, Yannuzzi LA, Jampol LM. Idiopathic polypoidal choroidal vasculopathy of the macula. Ophthalmology 1998;105:1380-5.
7. Uyama M, Matsubara T, Fukushima I, Matsunaga H, Iwashita K, Nagai Y, et al. Idiopathic polypoidal choroidal vasculopathy in Japanese patients. Arch Ophthalmol 1999;117:1035-42.
8. Ahuja RM, Stanga PE, Vingerling JR, Reck AC, Bird AC. Polypoidal choroidal vasculopathy in exudative and hemorrhagic pigment epithelial detachments. Br J Ophthalmol 2000;84:479-84.
9. Lafaut BA, Leys AM, Snyers B, Rasquin F, De Laey JJ. Idiopathic polypoidal choroidal vasculopathy in Caucasians. Graefes Arch Clin Exp Ophthalmol 2000;238:752-9.
10. Treatment of age related macular degeneration with photodynamic therapy (TAP) study group. Photodynamic therapy of subfoveal choroidal neovascularisation in age related macular degeneration with verteporfin. One-year results of 2 randomised clinical Trial- TAP report 1. Arch Ophthalmol 1999;117:1329-45.
11. Verteporfin In Photodynamic Therapy Study Group. Verteporfin therapy of subfoveal choroidal neovascularisaton in age related macular degeneration: Two year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularisation- verteporfin in photodynamic therapy report 2. Am J Ophthalmol 2001;131:541-60.
12. Verteporfin therapy for subfoveal choroidal neovascularisation in age related macular degeneration. Three-year results of an Open label extension of 2 randomised clinical trials-TAP report No. 5. Arch Ophthalmol 2002;120:1307-14.
13. Sickenberg M, Schmidt-Erfurth U, Miller JW, Pournaras CJ, Zografos L, Piguet B, et al. A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularisation in pathologic myopia, Ocular histoplasmosis syndrome, angioid streaks and idiopathic causes. Arch Ophthalmol 2000;118:327-36.
14. Verteporfin Therapy of subfoveal choroidal neovascularisation in pathologic myopia. 2-year results of a randomized clinical trial - Verteporfin in Photodynamic Therapy (VIP) Study Group. Report No. 3. Ophthalmology 2003;110:667-73.
15. Uyama M, Wada M, Nagai Y, Matsubara T, Matsunaga H, Fukushima I, Takahashi K, et al. Polypoidal choroidal vasculopathy: Natural history. Am J Ophthalmol 2002;133:639-48.
16. Shiraga F, Matsuo T, Yokoe S, Takasu I, Okanouchi T, Ohtsuki H, et al. Surgical Treatment of submacular hemorrhage associated with Idiopathic Polypoidal Choroidal Vasculopathy. Am J Ophthalmol 1999;128:147-54.
17. Spaide RF, Donsoff I, Lam DL, Yannuzzi LA, Jampol LM, Slakter J, et al. Treatment Polypoidal Choroidal vasculopathy with Photodynamic therapy. Retina 2002;22:529-35.
18. Lee SC, Seong YS, Kim SS, Koh HJ, Kwon OW. Photodynamic therapy with verteporfin for polypoidal choroidal vasculopathy of the macula. Ophthalmologica 2004;218:193-201.